IP Library Granted Patent US 8,163,277
Granted Patent B2
US 8,163,277 · App. 11/494,166 · Granted Apr 24, 2012

Kits for treating dysfunction of cardiac muscle

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,163,277
App. No.
11/494,166
Granted
Apr 24, 2012
Kind
B2
Abstract

Kits are described for the treatment of acute or chronic dysfunction of cardiac muscle. The kit includes a platelet-rich plasma composition with a pH adjusting agent and a catheter or syringe for delivery of the platelet-rich plasma composition to dysfunctional cardiac muscle. The kit may also include a syringe for withdrawing blood from a patient and a centrifuge device to obtain platelet-rich plasma.

Claims (16)

1. A delivery system for treating acute or chronic dysfunction of cardiac muscle comprising:

a platelet-rich plasma composition comprising platelet-rich plasma and a pH adjusting agent; and

a catheter for delivery of the platelet-rich plasma composition to dysfunctional cardiac muscle,

wherein the platelet-rich plasma composition does not contain an activator of the platelet-rich plasma.

2. The delivery system of claim 1 , wherein the pH adjusting agent provides a pH of about 7.3 to 7.5.

3. The delivery system of claim 1 , wherein the pH adjusting agent is a bicarbonate buffer.

4. The delivery system of claim 1 , wherein a plasma used for the platelet-rich plasma is from an autologous source.

5. The delivery system of claim 1 , further comprising an implantable device.

6. The delivery system of claim 5 , wherein the implantable device is a stent.

7. A kit for treating acute or chronic dysfunction of cardiac muscle comprising:

a syringe for withdrawing blood from a patient;

a centrifuge device to obtain platelet-rich plasma;

a pH adjusting agent for the platelet-rich plasma to provide a platelet-rich composition having a pH of about 7.3 to 7.5; and

a catheter for delivery of the platelet-rich plasma composition to dysfunctional cardiac muscle,

wherein the kit does not contain an activator of the platelet-rich plasma.

8. The kit of claim 7 , wherein the pH adjusting agent is a bicarbonate buffer.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 6, 2021
From: MISHRA, ALLAN, DR.
To: BLUE ENGINE BIOLOGICS, LLC
Reel/Frame 056759/0943 →